ArticleThe journal of prevention of Alzheimer's disease2026

Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data.

Bjoern O Schelter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.